Stock Price Quote

WOCKHARDT LTD.

NSE : WOCKPHARMABSE : 532300ISIN CODE : INE049B01025Industry : Pharmaceuticals & DrugsHouse : Wockhardt
BSE307.50-24.6 (-7.41 %)
PREV CLOSE ( ) 332.10
OPEN PRICE ( ) 324.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 192911
TODAY'S LOW / HIGH ( )301.05 329.00
52 WK LOW / HIGH ( )230 470.5
NSE307.35-25.1 (-7.55 %)
PREV CLOSE( ) 332.45
OPEN PRICE ( ) 321.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 307.35 (7308)
VOLUME 924171
TODAY'S LOW / HIGH( ) 300.00 328.90
52 WK LOW / HIGH ( )230.15 470.9
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 08-07 1999
Management Info
Habil Khorakiwala - Chairman Murtaza Khorakiwala - Managing Director
Registered Office

Address Wockhardt Research Centre,D-4, M.i.d.c,Chikalthana,
Aurangabad,
Maharashtra-431006

Phone 91-240-6632222

Email investorrelations@wockhardt.com

Website www.wockhardt.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, Luxembourg, MCX

NEWS

12Feb Wockhardt gets nod to sell some busine
Wockhardt has received approval for the transfer of business comprising..
28Jan Maruti Suzuki, NTPC and Ramco Industri
Maruti Suzuki India has changed the price for select models owing to inc..
28Jan Wockhardt jumps on turning black in Q3
Wockhardt is currently trading at Rs. 362.90, up by 10.00 points or 2.83..
27Jan Wockhardt turns black in Q3
Wockhardt has reported results for third quarter ended December 31, 2019..
16Jan Wockhardt gets DCGI’s nod for 2 new an
Wockhardt has received approval from Indian drug regulator -- Drug Contr..

Financials

in Millions
QTR Dec 19 ANNUAL 19
Net Profit-698.4-818.9
Gross Profit -868.6 -1754.3
Operating Profit 85.29999999999971171.1
Net Sales 3287.421499.5

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Pfizer (BSE)
peergroup  4200.45 (1.02%)
M.Cap ( in Cr)19216.11
Procter&Gamble Healt (BSE)
peergroup  4179.90 (0.33%)
M.Cap ( in Cr)6938.38
Ipca Laboratories (BSE)
peergroup  1361.70 (0.80%)
M.Cap ( in Cr)17205.37
Eris Lifesciences (BSE)
peergroup  433.60 (2.48%)
M.Cap ( in Cr)5887.45
Shree Ganesh Remed. (BSE)
peergroup  108.45 (7.80%)
M.Cap ( in Cr)97.29

Shareholding Pattern

PROMOTERS 72.4%
NON-INSTITUTION 22.18%
FI/BANKS/INSURANCE 0.13%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%

About Wockhardt Ltd.

Wockhardt Ltd. was incorporated in the year 1999. Its today's share price is 332.1. Its current market capitalisation stands at Rs 3405.1 Cr. In the latest quarter, company has reported Gross Sales of Rs. 41583.8 Cr and Total Income of Rs.41794 Cr. The company's management includes Zahabiya Khorakiwala, Murtaza Khorakiwala, Huzaifa Khorakiwala, Rima Marphatia, Vinesh Kumar Jairath, Baldev Raj Arora, Tasneem Mehta, Sanjaya Baru, Davinder Singh Brar, Aman Mehta, Habil Khorakiwala.

It is listed on the BSE with a BSE Code of 532300 , NSE with an NSE Symbol of WOCKPHARMA and ISIN of INE049B01025. It's Registered office is at Wockhardt Research Centre,D-4, M.i.d.c,ChikalthanaAurangabad-431006, Maharashtra. Their Registrars are ACC Ltd. It's auditors are Arthur Andersen & Associates, Haribhakti & Co, Haribhakti & Co LLP, SR Batliboi & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X